ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

APGE Apogee Therapeutics Inc

38.05
1.68 (4.62%)
20 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2023Dec 2023Mar 2024
USD (US$)
Total Revenue 000
Operating Income -24.31M-42.6M-38.18M
Pre Tax Income -20.84M-31.74M-32.09M
Net Income -20.84M-31.74M-32.09M
Preferred Dividends 000
Basic Earnings Per Share (EPS) 000
EBIT -24.31M-42.6M-38.18M
EBITDA -24.31M-42.6M-38.18M
Year End 31 December 2023 2023
USD (US$)
Total Revenue 0
Operating Income -93M
Pre Tax Income -83.99M
Net Income -83.99M
Preferred Dividends 0
Basic Earnings Per Share (EPS) -1.657
EBIT -93M
EBITDA -93M